{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:07:10Z","timestamp":1791407230954,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ejca.2010.04.018","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T02:17:41Z","timestamp":1275013061000},"page":"2275-2284","source":"Crossref","is-referenced-by-count":235,"title":["Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: A meta-analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"S.","family":"Iodice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rotmensz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Feroce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2010.04.018_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejca.2010.04.018_bib2","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2010.04.018_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/gyno.2001.6131","article-title":"BRCA: the breast, ovarian, and other cancer genes","volume":"80","author":"Boyd","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2010.04.018_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2010.04.018_bib5","first-page":"957","article-title":"Genetic heterogeneity of breast-ovarian cancer revisited. Breast cancer linkage consortium","volume":"57","author":"Narod","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejca.2010.04.018_bib6","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejca.2010.04.018_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12\u201313","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejca.2010.04.018_bib8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/302853","article-title":"BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer","volume":"66","author":"Moslehi","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejca.2010.04.018_bib9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2010.04.018_bib10","unstructured":"Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Lyon; 2005."},{"key":"10.1016\/j.ejca.2010.04.018_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2010.04.018_bib12","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2010.04.018_bib13","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","article-title":"Risk factors for triple-negative breast cancer in women under the age of 45 years","volume":"18","author":"Dolle","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2010.04.018_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2010.04.018_bib15","unstructured":"Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al., editors. SEER cancer statistics review, 1975\u20132006. Bethesda, MD: National Cancer Institute; 2009."},{"key":"10.1016\/j.ejca.2010.04.018_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2008.12.015","article-title":"BRCA1 and implications for response to chemotherapy in ovarian cancer","volume":"113","author":"Quinn","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2010.04.018_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2265.1998.00577.x","article-title":"Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence","volume":"49","author":"Riman","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejca.2010.04.018_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations","volume":"160","author":"McGuire","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2010.04.018_bib20","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case\u2013control studies. II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2010.04.018_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejca.2010.04.018_bib22","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713\u201327.","DOI":"10.1016\/S0140-6736(96)90806-5"},{"key":"10.1016\/j.ejca.2010.04.018_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2010.04.018_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jamia.1994.95153434","article-title":"Developing optimal search strategies for detecting clinically sound studies in MEDLINE","volume":"1","author":"Haynes","year":"1994","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.ejca.2010.04.018_bib25","first-page":"157","article-title":"Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy","volume":"4","author":"Shojania","year":"2001","journal-title":"Eff Clin Pract"},{"key":"10.1016\/j.ejca.2010.04.018_bib27","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2010.04.018_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0361-090X(02)00004-1","article-title":"Oral contraceptives and risk of familial breast cancer","volume":"26","author":"Heimdal","year":"2002","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.ejca.2010.04.018_bib29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1055-9965.EPI-06-0258","article-title":"BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50","volume":"15","author":"Haile","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2010.04.018_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10549-005-9051-5","article-title":"Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland","volume":"95","author":"Gronwald","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2010.04.018_bib31","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral contraceptives and breast cancer risk in the international BRCA1\/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating group","volume":"25","author":"Brohet","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.018_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00008571-200110000-00010","article-title":"Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives","volume":"11","author":"Runnebaum","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejca.2010.04.018_bib33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.bjc.6602239","article-title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations","volume":"91","author":"Whittemore","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2010.04.018_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case\u2013control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2010.04.018_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1055-9965.EPI-08-0546","article-title":"Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the international BRCA1\/2 carrier cohort study","volume":"18","author":"Antoniou","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2010.04.018_bib36","first-page":"3678","article-title":"Does oral contraceptive use increase the risk of breast cancer in women with BRCA1\/BRCA2 mutations more than in other women?","volume":"57","author":"Ursin","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2010.04.018_bib37","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ejca.2005.03.035","article-title":"Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing","volume":"41","author":"Jernstrom","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2010.04.018_bib38","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejca.2005.08.045","article-title":"Hormone replacement therapy is more prevalent among Jewish BRCA1\/2 mutation carriers","volume":"42","author":"Sade","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2010.04.018_bib39","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1158\/1055-9965.EPI-08-0396","article-title":"Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1\/2 mutation carriers and noncarriers: results from a population-based study","volume":"17","author":"Lee","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2010.04.018_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2010.04.018_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1024932427503","article-title":"Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)","volume":"14","author":"Modugno","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2010.04.018_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ejca.2010.04.018_bib43","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/sim.1184","article-title":"Statistical methods for assessing the influence of study characteristics on treatment effects in \u2018meta-epidemiological\u2019 research","volume":"21","author":"Sterne","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2010.04.018_bib44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2010.04.018_bib45","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods","volume":"18","author":"Thompson","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2010.04.018_bib46","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","article-title":"Methods for trend estimation from summarized dose\u2013response data, with applications to meta-analysis","volume":"135","author":"Greenland","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2010.04.018_bib47","doi-asserted-by":"crossref","unstructured":"van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med JID \u2013 8215016 2002;21:589\u2013624.","DOI":"10.1002\/sim.1040"},{"key":"10.1016\/j.ejca.2010.04.018_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1191\/096228001678227776","article-title":"A sensitivity analysis for publication bias in systematic reviews","volume":"10","author":"Copas","year":"2001","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ejca.2010.04.018_bib49","doi-asserted-by":"crossref","unstructured":"Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med JID \u2013 8215016 2001;20:641\u201354.","DOI":"10.1002\/sim.698"},{"key":"10.1016\/j.ejca.2010.04.018_bib50","unstructured":"SAS Institute Inc. SAS windows version. (8.02). Cary, NC: 1999."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804910003400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804910003400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:58:31Z","timestamp":1559131111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804910003400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0959804910003400"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2010.04.018","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}